These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18662265)

  • 1. Bilirubin concentration and cardiovascular risk profile.
    Lippi G; Targher G; Montagnana M; Salvagno GL; Guidi GC
    Liver Int; 2009 Feb; 29(2):315-6. PubMed ID: 18662265
    [No Abstract]   [Full Text] [Related]  

  • 2. [Some cardiovascular effects of alcohol. Prospective study on 200 patients between 2006-2008].
    Chetreanu L; Iliescu ML; Zdrenghea D
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):349-52. PubMed ID: 20700965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biochemical parameters of cardiovascular pathology risk in automobile drivers].
    Blinova TV; Troshin VV; Makarov IA; Strakhova LA; Morozova PN
    Med Tr Prom Ekol; 2012; (6):18-22. PubMed ID: 22997754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Total cardiovascular risk. When is a medication prophylaxis meaningful].
    Einecke D
    MMW Fortschr Med; 2003 Oct; 145(44):6-8. PubMed ID: 14655495
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fasting and nonfasting lipids--secondary publication].
    Langsted A; Freiberg JJ; Nordestgaard BG
    Ugeskr Laeger; 2009 Jun; 171(26):2184-7. PubMed ID: 19678434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up with HDL, the "good" cholesterol. Guidelines mainly target LDL cholesterol, but HDL matters, too.
    Harv Womens Health Watch; 2008 Jun; 15(10):2-3. PubMed ID: 18853517
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipid levels in women with androgenetic alopecia.
    Arias-Santiago S; Gutiérrez-Salmerón MT; Buendía-Eisman A; Girón-Prieto MS; Naranjo-Sintes R
    Int J Dermatol; 2010 Nov; 49(11):1340-2. PubMed ID: 20964664
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipoprotein patterns in adult cystic fibrosis: a cause for concern or marker for survival?
    Worgall TS
    Respirology; 2010 Jul; 15(5):731-2. PubMed ID: 20653919
    [No Abstract]   [Full Text] [Related]  

  • 9. CVD risk factors in rural women.
    Roddy SJ; Walker SN; Larsen J; Lindsey A; Shurmur S; Yates B
    Nurse Pract; 2007 Jun; 32(6):53-5. PubMed ID: 17557029
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating the incremental benefits of raising high-density lipoprotein cholesterol levels during lipid therapy after adjustment for the reductions in other blood lipid levels.
    Grover SA; Kaouache M; Joseph L; Barter P; Davignon J
    Arch Intern Med; 2009 Oct; 169(19):1775-80. PubMed ID: 19858435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyslipidemia therapy update: the importance of full lipid profile assessment.
    Menown IB; Murtagh G; Maher V; Cooney MT; Graham IM; Tomkin G
    Adv Ther; 2009 Jul; 26(7):711-8. PubMed ID: 19649582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homocysteine increases the risk associated with hyperlipidaemia.
    Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meet LDL's partner in plaque. ApoB puts the "bad" in bad cholesterol.
    Gebel E
    Diabetes Forecast; 2008 May; 61(5):39-40. PubMed ID: 18499924
    [No Abstract]   [Full Text] [Related]  

  • 14. The Editor's Roundtable: the metabolic syndrome.
    Friedewald VE; Grundy S; Gotto AM; Haffner S; Denke MA; Hollander P; Roberts WC
    Am J Cardiol; 2007 Feb; 99(3):382-9. PubMed ID: 17261403
    [No Abstract]   [Full Text] [Related]  

  • 15. Alcohol drinking and cardiovascular risk in a population with high mean alcohol consumption.
    Foerster M; Marques-Vidal P; Gmel G; Daeppen JB; Cornuz J; Hayoz D; Pécoud A; Mooser V; Waeber G; Vollenweider P; Paccaud F; Rodondi N
    Am J Cardiol; 2009 Feb; 103(3):361-8. PubMed ID: 19166690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences, anger expression, and cardiovascular risk.
    Doster JA; Purdum MB; Martin LA; Goven AJ; Moorefield R
    J Nerv Ment Dis; 2009 Jul; 197(7):552-4. PubMed ID: 19597365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between educational status and cardiovascular risk factors in an overweight and obese Turkish female population.
    Tanyolaç S; Sertkaya Cikim A; Doğan Azezli A; Orhan Y
    Anadolu Kardiyol Derg; 2008 Oct; 8(5):336-41. PubMed ID: 18849223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypertriglyceridemic waist phenotype versus the National Cholesterol Education Program-Adult Treatment Panel III and International Diabetes Federation clinical criteria to identify high-risk men with an altered cardiometabolic risk profile.
    Blackburn P; Lemieux I; Alméras N; Bergeron J; Côté M; Tremblay A; Lamarche B; Després JP
    Metabolism; 2009 Aug; 58(8):1123-30. PubMed ID: 19481769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abdominal obesity is associated with ineffective control of cardiovascular risk factors in primary care in France.
    Dallongeville J; Bringer J; Bruckert E; Charbonnel B; Dievart F; Komajda M; Pouchain D; Amouyel P
    Diabetes Metab; 2008 Dec; 34(6 Pt 1):606-11. PubMed ID: 19019717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High cholesterol level may protect against infections and probably also atherosclerosis].
    Ravnskov U
    Lakartidningen; 2004 Mar; 101(13):1215-7; discussion 1218, 1221-2. PubMed ID: 15101249
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.